Todd Smith and Benjamin Bove are known to have consulted at four pharmaceutical companies that subsequently raised prices on life-saving and other drugs by as much as 4,116 percent. Meanwhile, advocacy groups are asking the Trump administration to override patents on a pricey drug; the definition of "pharmacy" is expanded to help level the playing field; an investigation finds drugmakers flouting a law on disclosing their policies.
from Kaiser Health News https://ift.tt/2Hep6WZ
0 comments:
Post a Comment